The same officials said Trump would also highlight leucovorin, a cancer and anemia drug, as a potential therapy for people with autism. Last week, Kirk Perry, interim CEO of Tylenol maker Kenvue, privately urged Kennedy not to cite Tylenol as a cause, according to The Wall Street Journal. Political and legal implicationsCopy link to sectionTrump’s decision to elevate the issue marks the first time the US government would officially link acetaminophen to autism, contradicting decades of medical guidance. Kenvue already faces lawsuits from families who allege Tylenol caused their children’s autism or ADHD. A turning point for KenvueCopy link to sectionThe latest controversy poses a new reputational challenge for Kenvue, which was spun out of Johnson & Johnson in 2023.